Methylation Effects of COV-19 Infection and Vaccinations

NCT04939155 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-06-30

No results posted yet for this study

Summary

This is a retrospective non-randomized clinical study of 60 patients total to assess the effects of SARS-CoV-2 infection and the SARS-CoV-2 vaccination. This study will have 2 arms evaluating the epigenomes of patients pre and post-exposure to one of the interventions. The first arm of the study will analyze 40 patients' epigenomes whose DNA methylation was examined pre and post SARS-CoV-2 infection. The second arm of this study is analyzing 20 patients' epigenomes whose DNA methylation was examined pre and post-injection of the SARS-CoV-2 vaccine.

Conditions

  • Covid19

Interventions

BIOLOGICAL

SARS-CoV-2 mRNA vaccine

mRNA vaccine for COVID

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-10
Primary Completion
2021-10-01
Completion
2022-03-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04939155 on ClinicalTrials.gov